NFH
ARRY

NEXT Financial Holdings’s Array Biopharma Inc ARRY Stock Holding History

NEXT Financial Holdings’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$32K Buy
+1,300
New +$27.1K 0.01% 851

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

NEXT Financial Holdings's ARRY Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Array Biopharma Inc (ARRY) in Q1 2019: 1,300 shares worth $32K. The stake represents 0.01% of the portfolio and ranks #851 among its holdings.

268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • NEXT Financial Holdings held 1,300 shares of Array Biopharma Inc worth $32K as of Q1 2019.
  • Array Biopharma Inc was a new NEXT Financial Holdings position in Q1 2019.
  • Array Biopharma Inc made up 0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #851 holding.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.